tirzepatide brighton Weight Loss Injections Tirzepatide Weight Loss Program -

This is your bodys survival programming, not medication tolerance

Wegovy is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with a BMI of 30 kg/m2 or greater (obesity), adults with a BMI of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition and paediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and gender (obesity)

With monthly visits that include dedicated time to discuss your health concerns and goals, and a customized diet plan

Consistent, provider-supervised monitoring ensures safety and tolerability optimization throughout your treatment course

This is a standard rule across compounded prescription medications, not a policy specific to altRx